Literature DB >> 21733554

Interobserver agreement for Polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology.

Aylin Sar1, Suchin Worawichawong, Hallgrimur Benediktsson, Jianguo Zhang, Serdar Yilmaz, Kiril Trpkov.   

Abstract

A classification schema for grading Polyomavirus nephropathy was proposed at the 2009 Banff allograft meeting. The schema included 3 stages of Polyomavirus nephropathy: early (stage A), florid (stage B), and late sclerosing (stage C). Grading categories for histologic viral load levels were also proposed. To examine the applicability and the interobserver agreement of the proposed Polyomavirus nephropathy grading schema, we evaluated 24 renal allograft biopsies with confirmed Polyomavirus nephropathy by histology and SV40. Four renal pathologists independently scored the Polyomavirus nephropathy stage (A, B, or C), without knowledge of the clinical history. Viral load was scored as a percent of tubules exhibiting viral replication, using either a 3-tier viral load score (1: ≤1%; 2: >1%-10%; 3: >10%) or a 4-tier score (1: ≤1%; 2: >1%-≤5%; 3: >5%-15%; 4: >15%). The κ score for the Polyomavirus nephropathy stage was 0.47 (95% confidence interval, 0.35-0.60; P < .001). There was a substantial agreement using both the 3-tier and the 4-tier scoring for the viral load (Kendall concordance coefficients, 0.72 and 0.76, respectively; P < .001 for both). A better complete agreement was found using the 3-tier viral load score. In this first attempt to evaluate the interobserver reproducibility of the proposed Polyomavirus nephropathy classifying schema, we demonstrated moderate κ agreement in assessing the Polyomavirus nephropathy stage and a substantial agreement in scoring the viral load level. The proposed grading schema can be applied in routine allograft biopsy practice for grading the Polyomavirus nephropathy stage and the viral load level.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21733554     DOI: 10.1016/j.humpath.2011.03.008

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

1.  Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis.

Authors:  Melissa Krystel-Whittemore; Ellen T McCarthy; Ivan Damjanov; Timothy A Fields
Journal:  BMJ Case Rep       Date:  2015-08-28

2.  The Importance of Kidney Medullary Tissue for the Accurate Diagnosis of BK Virus Allograft Nephropathy.

Authors:  Brian J Nankivell; Jasveen Renthawa; Meena Shingde; Asrar Khan
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-01       Impact factor: 8.237

3.  Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.

Authors:  Thurid Ahlenstiel-Grunow; Lars Pape
Journal:  Pediatr Nephrol       Date:  2018-12-11       Impact factor: 3.714

4.  Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.

Authors:  Adnan Sharif; Nada Alachkar; Serena Bagnasco; Duvuru Geetha; Gaurav Gupta; Karl Womer; Lois Arend; Lorraine Racusen; Robert Montgomery; Edward Kraus
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 8.237

5.  The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.

Authors:  Volker Nickeleit; Harsharan K Singh; Parmjeet Randhawa; Cinthia B Drachenberg; Ramneesh Bhatnagar; Erika Bracamonte; Anthony Chang; W James Chon; Darshana Dadhania; Vicki G Davis; Helmut Hopfer; Michael J Mihatsch; John C Papadimitriou; Stefan Schaub; Michael B Stokes; Mohammad F Tungekar; Surya V Seshan
Journal:  J Am Soc Nephrol       Date:  2017-12-26       Impact factor: 10.121

6.  Banff Classification of Polyomavirus Nephropathy: A New Tool for Research and Clinical Practice.

Authors:  Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 10.121

7.  The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.

Authors:  K Masutani; R Shapiro; A Basu; H Tan; M Wijkstrom; P Randhawa
Journal:  Am J Transplant       Date:  2012-03-05       Impact factor: 8.086

8.  Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.

Authors:  Thurid Ahlenstiel-Grunow; Lars Pape
Journal:  Pediatr Nephrol       Date:  2019-12-19       Impact factor: 3.714

9.  Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.

Authors:  B Adam; P Randhawa; S Chan; G Zeng; H Regele; Y B Kushner; R B Colvin; J Reeve; M Mengel
Journal:  Am J Transplant       Date:  2014-08-04       Impact factor: 8.086

10.  Noninvasive prognostication of polyomavirus BK virus-associated nephropathy.

Authors:  Darshana Dadhania; Catherine Snopkowski; Thangamani Muthukumar; John Lee; Ruchuang Ding; Vijay K Sharma; Paul Christos; Heejung Bang; Sandip Kapur; Surya V Seshan; Manikkam Suthanthiran
Journal:  Transplantation       Date:  2013-07-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.